Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis

NCT03615677 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Esophagitis (EE)

Interventions

DRUG: LXI-15028 50mg
DRUG: Esomeprazole 40mg

Sponsor

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.